Trial Profile
Randomised trial of adjuvant hepatic intra-arterial iodine-131-lipiodol [ethiodized oil] following curative resection of hepatocellular carcinoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 Jun 2007 Status changed from recruiting to in progress
- 16 Sep 2005 New trial record.